StreetInsider.com News Articles

H.C. Wainwright Reiterates Buy Rating on MindWalk Holdings (HYFT)

Thu, 02 Jul 2026 06:44:12 -0400

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $5.00 price target on MindWalk Holdings (NASDAQ: HYFT).

The analyst commented: "On July 1, MindWalk announced the filing of European patent application No. EP26187897.9, directed to high-dimensional data structures for biological sub-sequences and property inference. The application is intended to protect the enriched biological representation architecture that underpins the company's HYFT Technology, its ReefIQ biological context layer, and its LensAI reasoning workflows. It builds on the foundational HYFT patent (EP3881326A1), adding a distinct computational layer that organizes biological meaning around HYFT pattern anchors so it can be reused across the company's

Form 6-K MindWalk Holdings Corp. For: Jul 01

Wed, 01 Jul 2026 09:54:00 -0400

si-local-file:///var/storage/secattach/20260701/26718181.html

Form 6-K MindWalk Holdings Corp. For: Jul 01

Wed, 01 Jul 2026 09:54:00 -0400

si-local-file:///var/storage/secattach/20260701/26718181.html

MindWalk files European patent for biological data architecture

Wed, 01 Jul 2026 08:00:38 -0400

MindWalk Holdings Corp. (NASDAQ: HYFT) has filed European patent application No. EP26187897.9, covering high-dimensional data structures for biological subsequences and property inference, the company announced.

The application seeks to protect the biological representation architecture that underpins the company's HYFT® Technology, its ReefIQ™ biological context layer, and its LensAI™ reasoning workflows. The filing builds on MindWalk's existing European patent EP3881326A1, which covers the identification of recurring biological patterns used as a searchable language for sequence comparison.

According to the company, the new application addresses a distinct layer above that foundation, seeking protection for how subsequence-level pattern anchors can be enriched with biological context

MindWalk files European patent for biological data architecture

Wed, 01 Jul 2026 08:00:38 -0400

According to the company, the new application addresses a distinct layer above that foundation, seeking protection for how subsequence-level pattern anchors can be enriched with biological context

MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery

Wed, 01 Jul 2026 08:00:00 -0400

The patent covers the multi-dimensional biological representation layer organized around MindWalk’s HYFT® pattern anchors — the model-agnostic context layer designed to support ReefIQ™, LensAI™, and customer-selected AI workflows as they retrieve, compare, and reason over connected, traceable biology in drug discovery.

AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today announced the filing of European patent application No. EP26187897.9, directed to high-dimensional data structures for biological subsequences and property inference. The application is intended to protect the enriched biological representation architecture that underpins MindWalk's HYFT® Technology, its ReefIQ™ biological context layer, and its

MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery

Wed, 01 Jul 2026 08:00:00 -0400

MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery

Wed, 01 Jul 2026 08:00:00 -0400

MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery

Wed, 01 Jul 2026 08:00:00 -0400

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Tue, 16 Jun 2026 08:45:00 -0400